indirubin has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hu, Y; Miao, K; Mou, Y; Pan, T; Wang, Q; Wang, Y; Xiong, W; Xu, Y; Yu, J; Zhang, L | 1 |
1 other study(ies) available for indirubin and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
Topics: Animals; Bleomycin; Cell Differentiation; Cells, Cultured; Fibroblasts; Idiopathic Pulmonary Fibrosis; Indoles; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Pneumonia; Transforming Growth Factor beta1 | 2020 |